Active Ingredient: LITHIUM CARBONATE
Proprietary Name: LITHIUM CARBONATE
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 300MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076832
Product Number: 001
Approval Date: Oct 28, 2004
Applicant Holder Full Name: HIKMA PHARMACEUTICALS USA INC
Marketing Status:
Prescription
Patent and Exclusivity Information